Ex Scientia Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ex Scientia Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2805
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ex Scientia Ltd (Ex Scientia) is a biotechnology company that develops compounds with tailored polypharmacology. The company develops a systematic approach to tailoring drugs against polypharmacology profiles for superior clinical efficacy. It also develops molecular design technologies. EX Scientia offers underpinned by predictive models derived from the quantitative encoding of pharmacology. The company also offers drug design, bispecific drugs, polypharmacology and data driven drug design, among others. It serves pharmaceutical industry. The company conducts experiments for selection of information-rich compounds for synthesis and assay. Ex Scientia is headquartered in Dundee, the UK.

Ex Scientia Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ex Scientia Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Exscientia Enters into Partnership with GlaxoSmithKline (GSK) 10
Ex Scientia Enters into Research and Option Agreement with Sanofi 11
Sanofi Enters into Research Agreement with Exscientia 12
Evotec Forms Partnership with Ex Scientia 13
ex scientia Enters into Research Agreement with Sunovion Pharma 14
ex scientia Enters into Agreement with Japanese Pharma Company 15
ex scientia Enters into Agreement with Janssen Research & Development 16
Acquisition 17
Evotec Acquires Minority Stake in Exscientia for USD17.6 Million 17
Ex Scientia Ltd – Key Competitors 18
Ex Scientia Ltd – Key Employees 19
Ex Scientia Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Corporate Communications 21
Dec 11, 2017: Exscientia Appoints Alex Snow, Founder of Oxford Innovation Sciences and Former CEO of Lansdowne Partners, as Deputy Chairman 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ex Scientia Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ex Scientia Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Exscientia Enters into Partnership with GlaxoSmithKline (GSK) 10
Ex Scientia Enters into Research and Option Agreement with Sanofi 11
Sanofi Enters into Research Agreement with Exscientia 12
Evotec Forms Partnership with Ex Scientia 13
ex scientia Enters into Research Agreement with Sunovion Pharma 14
ex scientia Enters into Agreement with Japanese Pharma Company 15
ex scientia Enters into Agreement with Janssen Research & Development 16
Evotec Acquires Minority Stake in Exscientia for USD17.6 Million 17
Ex Scientia Ltd, Key Competitors 18
Ex Scientia Ltd, Key Employees 19
Ex Scientia Ltd, Other Locations 20

List of Figures
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Ex Scientia Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SNC-Lavalin Group Inc.:企業の戦略・SWOT・財務情報
    SNC-Lavalin Group Inc. - Strategy, SWOT and Corporate Finance Report Summary SNC-Lavalin Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Genome Institute of Singapore:製薬・医療:M&Aディール及び事業提携情報
    Summary Genome Institute of Singapore (GIS) is a research institute that provides research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It operates technology and comprises early career researchers such …
  • Stockland Corp Ltd:企業の戦略・SWOT・財務分析
    Stockland Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Stockland Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CITIC Securities Company Limited:企業の戦略・SWOT・財務情報
    CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Electricity Generating Public Co Ltd (EGCO):電力:M&Aディール及び事業提携情報
    Summary Electricity Generating Public Co Ltd (EGCO), a subsidiary of Electricity Generating Authority of Thailand (EGAT), is an energy utility. It produces electricity from natural gas, coal, biomass, waste, hydro, solar, wind, and geothermal sources. Through interests in independent power producer …
  • Sea Run Holdings Inc:製品パイプライン分析
    Summary Sea Run Holdings Inc (Sea Run Holdings) is a healthcare solutions provider that discovers and develops innovative reagents and therapeutics. The company’s pipeline products include salmon plasma and salmon fibrin products. Its salmon plasma product provides effective treatment for acute pain …
  • Viridian Energy Supply Ltd:企業の戦略的SWOT分析
    Viridian Energy Supply Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Orbit International Corp.:戦略・SWOT・企業財務分析
    Orbit International Corp. - Strategy, SWOT and Corporate Finance Report Summary Orbit International Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Royal Caribbean Cruises Ltd.:戦略・SWOT・企業財務分析
    Royal Caribbean Cruises Ltd. - Strategy, SWOT and Corporate Finance Report Summary Royal Caribbean Cruises Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Big Rivers Electric Corporation:企業の発電所・SWOT分析2018
    Big Rivers Electric Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • The Abraaj Group-エネルギー分野:企業M&A・提携分析
    Summary The Abraaj Group (Abraaj) is a financial service provider that offers private equity, investment and credit strategies for real estate operations. The company helps companies in their operational improvements, management incentives, optimization of capital structure and the use of leverage. …
  • National Jewish Health-製薬・医療分野:企業M&A・提携分析
    Summary National Jewish Health (NJH), formerly National Jewish Medical and Research Center is a healthcare center that offers treatment of pulmonary, cardiac, immune and related disorders. The center offers services in the areas of allergy, asthma, cardiology, clinical immunology, COPD, environmenta …
  • Standard Chartered Bank Botswana Ltd (STANCHART):企業の財務・戦略的SWOT分析
    Standard Chartered Bank Botswana Ltd (STANCHART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • General Cable Corp:電力:M&Aディール及び事業提携情報
    Summary General Cable Corp (General Cable), a subsidiary of Prysmian Group, produces and sells wires and cables. It develops, designs, manufactures, markets and distributes copper, aluminum and fiber optic wire and cable products for the energy, industrial, specialty, construction and communications …
  • Pharmaxis Ltd (PXS)-医療機器分野:企業M&A・提携分析
    Summary Pharmaxis Ltd (Pharmaxis) is a pharmaceutical research company that develops and commercialize healthcare products. The company offers products such as aridol which identify twitchy and assist in diagnosing and managing asthma, and bronchitol which restores normal lung hydration, improves lu …
  • Shantui Construction Machinery Co Ltd:企業の戦略・SWOT・財務情報
    Shantui Construction Machinery Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Shantui Construction Machinery Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Astellas Pharma Inc.:企業の戦略・SWOT・財務情報
    Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report Summary Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Volkswagen Financial Services AG:企業の戦略・SWOT・財務情報
    Volkswagen Financial Services AG - Strategy, SWOT and Corporate Finance Report Summary Volkswagen Financial Services AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • OraSure Technologies Inc (OSUR)-製薬・医療分野:企業M&A・提携分析
    Summary OraSure Technologies Inc (OraSure) is a manufacturer and distributor of oral fluid specimen collection devices, diagnostic products and other medical devices. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; and ant …
  • Escalon Medical Corp (ESMC):医療機器:M&Aディール及び事業提携情報
    Summary Escalon Medical Corp (Escalon) is a medical device company with primary focus on ophthalmology. It carries out the development and sale of ophthalmic medical devices. Its major products include A-Scan and B-Scan diagnostic tools, UBM high frequency/high resolution ultrasound devices, pachyme …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆